Rizatriptan in acute treatment of migraine: Update on new comparative data

Cephalalgia, Supplement

Volumn 20, Issue 1, 2000, Pages 10-15

  Goadsby, P J ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NARATRIPTAN; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN;

CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG INDICATION; DRUG RESEARCH; HUMAN; MIGRAINE;

EID: 0034453771     PISSN: 08001952     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2000.020s1010.x     Document Type: Conference Paper

References (18)

1. 1B/1D agonists in migraine: Comparative pharmacology and its therapeutic implications
2. Acute migraine therapy: Do doctors understand what patients with migraine want from therapy?
3. Guidelines for controlled trials of drugs in migraine
4. 1D receptor agonist MK-462
5. Rizatriptan (MAXALT) for the acute treatment of migraine and migraine reference. A placebo-controlled, outpatient study
6. Efficacy and safety of rizatriptan wafer for the acute treatment of migraine
7. Triptan too far
8. 1D agonist
9. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan
10. Time-to-event analysis, or who gets better sooner? An emerging concept in headache study methodology
11. Marginal likelihoods based on Cox's regression and life model
12. Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine
13. Mechanisms of action of rizatriptan: Insights into migraine pathophysiology
14. Comparison of rizatriptan 10 mg vs naratriptan 2.5 mg in migraine
15. Naratriptan in the treatment of acute migraine attacks
16. Oral naratriptan tablets (2.5mg-10mg) exhibit dose-proportional pharmacokinetics
17. Comparison of rizatriptan 10mg versus zolmitriptan 2.5 mg in migraine
18. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks